Recent studies on bleomycin.
D000626:Aminopeptidases / Q000037:antagonists & inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001665:Binding Sites; D001761:Bleomycin / Q000096:biosynthesis / Q000378:metabolism / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D003300:Copper / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004151:Dipeptides / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006867:Hydrolases / Q000378:metabolism; D010692:Phleomycins; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D004151:Dipeptides; D010692:Phleomycins; D001761:Bleomycin; D003300:Copper; D004247:DNA; D006867:Hydrolases; D000626:Aminopeptidases